Form 8-K - Current report:
SEC Accession No. 0001628280-25-020057
Filing Date
2025-04-25
Accepted
2025-04-25 17:24:38
Documents
17
Period of Report
2025-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K intensity-20250424.htm   iXBRL 8-K 39183
2 EX-4.1 exhibit41-8xk42525.htm EX-4.1 130710
3 EX-4.2 exhibit42-8xk42525.htm EX-4.2 130461
4 EX-10.1 exhibit101-8xk42525.htm EX-10.1 264167
5 EX-99.1 exhibit991-8xk42525.htm EX-99.1 13706
  Complete submission text file 0001628280-25-020057.txt   823258

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT intensity-20250424.xsd EX-101.SCH 1827
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT intensity-20250424_lab.xml EX-101.LAB 23449
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT intensity-20250424_pre.xml EX-101.PRE 13606
19 EXTRACTED XBRL INSTANCE DOCUMENT intensity-20250424_htm.xml XML 2935
Mailing Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484
Business Address 1 ENTERPRISE DRIVE, SUITE 430 SHELTON CT 06484 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

EIN.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 25875303
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)